**Core Concept**
Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, leading to bone marrow failure and peripheral blood cytopenias. The pathophysiology involves genetic mutations that disrupt normal cell differentiation and proliferation.

**Why the Correct Answer is Right**
MDS are most commonly diagnosed in the elderly population, with a median age of 70 years. This is due to the accumulation of genetic mutations and epigenetic alterations over time, which can occur due to various factors such as aging, exposure to environmental toxins, and previous chemotherapy or radiation therapy. The likelihood of developing MDS increases with age, with the majority of cases occurring in individuals over 60 years old.

**Why Each Wrong Option is Incorrect**
**Option A:** This age group is less likely to develop MDS, as the majority of cases occur in individuals over 60 years old.
**Option B:** While some cases of MDS can occur in younger individuals, such as those with a family history of the disease or previous exposure to chemotherapy, this age group is not the most common.
**Option C:** This age group is not typically associated with an increased risk of developing MDS.

**Clinical Pearl / High-Yield Fact**
MDS are often diagnosed incidentally during a routine complete blood count (CBC) or bone marrow biopsy, highlighting the importance of regular hematological monitoring in the elderly population.

**Correct Answer:** C.